Credit Suisse’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $7.8M | Buy |
|
|||||
|
2023
Q4 | $8.96M | Sell |
|
|||||
|
2023
Q3 | $3.32M | Sell |
|
|||||
|
2023
Q2 | $4.06M | Buy |
|
|||||
|
2023
Q1 | $3.58M | Buy |
|
|||||
|
2022
Q4 | $4.5M | Buy |
|
|||||
|
2022
Q3 | $4.73M | Buy |
|
|||||
|
2022
Q2 | $3.67M | Sell |
|
|||||
|
2022
Q1 | $3.46M | Buy |
|
|||||
|
2021
Q4 | $3.92M | Sell |
|
|||||
|
2021
Q3 | $3.1M | Sell |
|
|||||
|
2021
Q2 | $1.93M | Sell |
|
|||||
|
2021
Q1 | $2.83M | Sell |
|
|||||
|
2020
Q4 | $3.92M | Buy |
|
|||||
|
2020
Q3 | $2.84M | Buy |
|
|||||
|
2020
Q2 | $2M | Buy |
|
|||||
|
2020
Q1 | $313K | Sell |
|
|||||
|
2019
Q4 | $368K | Sell |
|
|||||
|
2019
Q3 | $695K | Buy |
|
|||||
|
2019
Q2 | $331K | Sell |
|
|||||
|
2019
Q1 | $253K | Buy |
|
|||||
|
2018
Q4 | $149K | Buy |
|
|||||
|
2018
Q3 | $175K | Sell |
|
|||||
|
2018
Q2 | $259K | Sell |
|
|||||
|
2018
Q1 | $266K | Buy |
|
|||||
|
2017
Q4 | $262K | Sell |
|
|||||
|
2017
Q3 | $784K | Buy |
|
|||||
|
2017
Q2 | $537K | Buy |
|
|||||
|
2017
Q1 | $388K | Buy |
|
|||||
|
2016
Q4 | $249K | Sell |
|
|||||
|
2016
Q3 | $297K | Buy |
|
|||||
|
2016
Q2 | $216K | Sell |
|
|||||
|
2016
Q1 | $199K | Sell |
|
|||||
|
2015
Q4 | $475K | Buy |
|
|||||
|
2015
Q3 | $90K | Sell |
|
|||||
|
2015
Q2 | $102K | Sell |
|
|||||
|
2015
Q1 | $192K | Sell |
|
|||||
|
2014
Q4 | $274K | Sell |
|
|||||
|
2014
Q3 | $233K | Sell |
|
|||||
|
2014
Q2 | $471K | Buy |
|
|||||
|
2014
Q1 | $369K | Sell |
|
|||||
|
2013
Q4 | $548K | Buy |
|
|||||
|
2013
Q3 | $496K | Buy |
|